These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 21084406

  • 1. Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats.
    Landgraf SS, Wengert M, Silva JS, Zapata-Sudo G, Sudo RT, Takiya CM, Pinheiro AA, Caruso-Neves C.
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F499-510. PubMed ID: 21084406
    [Abstract] [Full Text] [Related]

  • 2. Transient AT1 receptor-inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age.
    Baumann M, Janssen BJ, Hermans JJ, Peutz-Kootstra C, Witzke O, Smits JF, Struijker Boudier HA.
    J Hypertens; 2007 Jan; 25(1):207-15. PubMed ID: 17143193
    [Abstract] [Full Text] [Related]

  • 3. Glomerular losartan (DuP 753)-sensitive angiotensin II receptor density is increased in young spontaneously hypertensive rats.
    Haws RM, Shaul PW, Arant BS, Atiyeh BA, Seikaly MG.
    Pediatr Res; 1994 Jun; 35(6):671-6. PubMed ID: 7936816
    [Abstract] [Full Text] [Related]

  • 4. Increases in renal angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rats.
    Matsushima Y, Kawamura M, Akabane S, Imanishi M, Kuramochi M, Ito K, Omae T.
    J Hypertens; 1988 Oct; 6(10):791-6. PubMed ID: 3198916
    [Abstract] [Full Text] [Related]

  • 5. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D, Tanabe A, Naruse M, Morikawa S, Ezaki T, Takano K.
    Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
    [Abstract] [Full Text] [Related]

  • 6. Long-term inhibition of angiotensin prevents reduction of periarterial innervation of calcitonin gene-related peptide (CGRP)-containing nerves in spontaneously hypertensive rats.
    Hobara N, Gessei-Tsutsumi N, Goda M, Takayama F, Akiyama S, Kurosaki Y, Kawasaki H.
    Hypertens Res; 2005 May; 28(5):465-74. PubMed ID: 16156511
    [Abstract] [Full Text] [Related]

  • 7. Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats.
    Heijnen BF, Van Essen H, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA.
    Hypertens Res; 2014 Feb; 37(2):100-9. PubMed ID: 23985702
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M.
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA, Rattan S.
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
    Abdulla MH, Sattar MA, Abdullah NA, Hazim AI, Anand Swarup KR, Rathore HA, Khan MA, Johns EJ.
    Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
    [Abstract] [Full Text] [Related]

  • 11. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
    Nakamura T, Honma H, Ikeda Y, Kuroyanagi R, Takano H, Obata J, Sato T, Kimura H, Yoshida Y, Tamura K.
    Blood Press Suppl; 1994 Oct; 5():61-6. PubMed ID: 7889203
    [Abstract] [Full Text] [Related]

  • 12. Differential effect of losartan in female and male spontaneously hypertensive rats.
    de P Rodrigues SF, dos Santos RA, Silva-Antonialli MM, Scavone C, Nigro D, Carvalho MH, de Cássia Tostes R, Fortes ZB.
    Life Sci; 2006 Apr 04; 78(19):2280-5. PubMed ID: 16337658
    [Abstract] [Full Text] [Related]

  • 13. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS.
    Nephrol Dial Transplant; 2010 Feb 04; 25(2):389-99. PubMed ID: 19749146
    [Abstract] [Full Text] [Related]

  • 14. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension.
    Arendshorst WJ, Chatziantoniou C, Daniels FH.
    Kidney Int Suppl; 1990 Nov 04; 30():S92-6. PubMed ID: 2259085
    [Abstract] [Full Text] [Related]

  • 15. Sustained tubulo-interstitial protection in SHRs by transient losartan treatment: an effect of decelerated aging?
    Baumann M, Bartholome R, Peutz-Kootstra CJ, Smits JF, Struijker-Boudier HA.
    Am J Hypertens; 2008 Feb 04; 21(2):177-82. PubMed ID: 18188163
    [Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin II type 1 receptor blockade on the oxidative stress in spontaneously hypertensive rat tissues.
    Polizio AH, Peña C.
    Regul Pept; 2005 May 15; 128(1):1-5. PubMed ID: 15721481
    [Abstract] [Full Text] [Related]

  • 17. Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.
    Helle F, Iversen BM, Chatziantoniou C.
    Am J Physiol Renal Physiol; 2010 May 15; 298(5):F1170-7. PubMed ID: 20219827
    [Abstract] [Full Text] [Related]

  • 18. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
    Han WQ, Wu LY, Zhou HY, Zhang J, Che ZQ, Wu YJ, Liu JJ, Zhu DL, Gao PJ.
    Clin Exp Pharmacol Physiol; 2009 May 15; 36(5-6):583-8. PubMed ID: 19673944
    [Abstract] [Full Text] [Related]

  • 19. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP, Pang YJ, Zhu WW, Zhao TT, Zheng M, Wang YB, Sun ZJ, Sun SJ.
    Clin Exp Pharmacol Physiol; 2009 Mar 15; 36(3):287-96. PubMed ID: 19018797
    [Abstract] [Full Text] [Related]

  • 20. Characterization and hemodynamic implications of renal vascular angiotensin II receptors in SHR.
    Haddad G, Garcia R.
    J Mol Cell Cardiol; 1996 Feb 15; 28(2):351-61. PubMed ID: 8729067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.